195 related articles for article (PubMed ID: 16318410)
1. EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice.
Shir A; Ogris M; Wagner E; Levitzki A
PLoS Med; 2006 Jan; 3(1):e6. PubMed ID: 16318410
[TBL] [Abstract][Full Text] [Related]
2. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glioma growth by tumor-specific activation of double-stranded RNA-dependent protein kinase PKR.
Shir A; Levitzki A
Nat Biotechnol; 2002 Sep; 20(9):895-900. PubMed ID: 12205508
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.
Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A
Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446
[TBL] [Abstract][Full Text] [Related]
5. Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR.
Pandita A; Aldape KD; Zadeh G; Guha A; James CD
Genes Chromosomes Cancer; 2004 Jan; 39(1):29-36. PubMed ID: 14603439
[TBL] [Abstract][Full Text] [Related]
6. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
[TBL] [Abstract][Full Text] [Related]
8. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of F90, an epidermal growth factor receptor tyrosine kinase inhibitor, on glioblastoma cell line SHG-44.
Liu FJ; Gui SB; Li CZ; Sun ZL; Zhang YZ
Chin Med J (Engl); 2008 Sep; 121(17):1702-6. PubMed ID: 19024103
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentration.
Schulte A; Günther HS; Martens T; Zapf S; Riethdorf S; Wülfing C; Stoupiec M; Westphal M; Lamszus K
Clin Cancer Res; 2012 Apr; 18(7):1901-13. PubMed ID: 22316604
[TBL] [Abstract][Full Text] [Related]
11. Ligand mediated activation of ectopic EGF receptor promotes matrix protein adhesion and lung colonization of rat mammary adenocarcinoma cells.
Lichtner RB; Kaufmann AM; Kittmann A; Rohde-Schulz B; Walter J; Williams L; Ullrich A; Schirrmacher V; Khazaie K
Oncogene; 1995 May; 10(9):1823-32. PubMed ID: 7753557
[TBL] [Abstract][Full Text] [Related]
12. Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with NVP-AEE788 for the treatment of aggressive follicular thyroid cancer.
Younes MN; Yazici YD; Kim S; Jasser SA; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3425-34. PubMed ID: 16740767
[TBL] [Abstract][Full Text] [Related]
13. 4-(3'-Bromo-4'hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells.
Narla RK; Liu XP; Myers DE; Uckun FM
Clin Cancer Res; 1998 Jun; 4(6):1405-14. PubMed ID: 9626456
[TBL] [Abstract][Full Text] [Related]
14. Anti-EGFR activation, anti-proliferative and pro-apoptotic effects of polyclonal antibodies induced by EGFR-based cancer vaccine.
Ramírez BS; Alpízar YA; Fernández DR; Hidalgo GG; Capote AR; Rodríguez RP; Fernández LE
Vaccine; 2008 Sep; 26(38):4918-26. PubMed ID: 18672015
[TBL] [Abstract][Full Text] [Related]
15. Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe.
Diagaradjane P; Orenstein-Cardona JM; Colón-Casasnovas NE; Deorukhkar A; Shentu S; Kuno N; Schwartz DL; Gelovani JG; Krishnan S
Clin Cancer Res; 2008 Feb; 14(3):731-41. PubMed ID: 18245533
[TBL] [Abstract][Full Text] [Related]
16. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
17. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer.
Zhang Y; Zhang YF; Bryant J; Charles A; Boado RJ; Pardridge WM
Clin Cancer Res; 2004 Jun; 10(11):3667-77. PubMed ID: 15173073
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor (EGF) induces apoptosis in a transfected cell line expressing EGF receptor on its membrane.
Zhao X; Dai W; Zhu H; Zhang Y; Cao L; Ye Q; Lei P; Shen G
Cell Biol Int; 2006 Aug; 30(8):653-8. PubMed ID: 16750403
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis.
Mazzoleni S; Politi LS; Pala M; Cominelli M; Franzin A; Sergi Sergi L; Falini A; De Palma M; Bulfone A; Poliani PL; Galli R
Cancer Res; 2010 Oct; 70(19):7500-13. PubMed ID: 20858720
[TBL] [Abstract][Full Text] [Related]
20. Selective downregulation of EGF receptor and downstream MAPK pathway in human cancer cell lines by active components partially purified from the seeds of Livistona chinensis R. Brown.
Huang WC; Hsu RM; Chi LM; Leu YL; Chang YS; Yu JS
Cancer Lett; 2007 Apr; 248(1):137-46. PubMed ID: 16919867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
